Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Interest Expenses (2016 - 2026)

Apyx Medical filings provide 11 years of Interest Expenses readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 14.88% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 5.38% decrease, with the full-year FY2025 number at $5.6 million, down 5.38% from a year prior.
  • Interest Expenses hit $1.4 million in Q4 2025 for Apyx Medical, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.7 million in Q4 2024 to a low of $1000.0 in Q4 2021.
  • Median Interest Expenses over the past 5 years was $564000.0 (2023), compared with a mean of $699950.0.
  • Biggest five-year swings in Interest Expenses: crashed 88.0% in 2021 and later skyrocketed 58400.0% in 2023.
  • Apyx Medical's Interest Expenses stood at $1000.0 in 2021, then skyrocketed by 200.0% to $3000.0 in 2022, then surged by 37100.0% to $1.1 million in 2023, then soared by 48.12% to $1.7 million in 2024, then decreased by 14.88% to $1.4 million in 2025.
  • The last three reported values for Interest Expenses were $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.